The Balance of Thrombosis and Hemorrhage in Surgery

Hematology/Oncology Clinics of North America

Volumn 21, Issue 1, 2007, Pages 13-24

  Adams, George L ^a   Manson, Roberto J ^a   Turner, Immanuel ^a   Sindram, David ^a   Lawson, Jeffrey H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTITHROMBIN III; APROTININ; DESMOPRESSIN; FIBRINOGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FRESH FROZEN PLASMA; INTERLEUKIN 1; LYSINE DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PROTEIN C; PROTEIN S; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TISSUE FACTOR PATHWAY INHIBITOR; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR; VON WILLEBRAND FACTOR;

BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CELL LEVEL; CLINICAL TRIAL; CRYOPRECIPITATE; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; LABORATORY TEST; LIVER TRANSPLANTATION; MULTIPLE TRAUMA; ORTHOPEDIC SURGERY; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SCREENING; THROMBOSIS; TREATMENT OUTCOME;

BLOOD COAGULATION; HEMORRHAGE; HUMANS; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, OPERATIVE; THROMBOSIS;

EID: 33846469007     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.11.013     Document Type: Review

References (38)

1. Davie E.W., and Ratnoff O.D. Waterfall sequence of intrinsic blood clotting. Science 145 (1964) 1310-1312
2. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 202 (1964) 4998-4999
3. Becker R.C. Cell-based models of coagulation: a paradigm in evolution. J Thromb Thrombolysis 20 1 (2005) 65-68
4. Giesen P.L., Rauch U., Bohrmann B., et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 96 (1999) 2311-2315
5. Hartzell S., Ryder K., Lanahan A., et al. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol 9 (1989) 2567-2573
6. Bevilacqua M.P., Pober J.S., Majeau G.R., et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160 (1984) 618-623
7. Scarpati E.M., and Sadler J.E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 264 (1989) 20705-20713
8. De Cristofaro R., and De Candia E. Thrombin domains: structure, function and interaction with platelet receptors. J Thromb Thrombolysis 15 (2003) 151-163
9. Savage B., Sixma J.J., and Ruggeri Z.M. Functional self-association of von Willebrand factor during platelet adhesion under flow. Proc Nat Acad Sci U S A 99 (2002) 425-430
10. Walsh P.N. Roles of platelets and factor XI in the initiation of blood coagulation and thrombin. Thromb Haemost 86 (2001) 75-82
11. Rapaport S.I. Preoperative hemostatic evaluation: which tests, if any?. Blood 61 2 (1983) 229-231
12. Stuart M.J., Miller M.L., Davey F.R., et al. The post-aspirin bleeding time: a screening test for evaluating haemostatic disorders. Br J Haematol 43 (1979) 649-659
13. Colman R.W., Bagdasarian A., and Talama R.C. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 56 (1975) 1650-1662
14. Koh M.B., and Hunt B.J. The management of perioperative bleeding. Blood Rev 17 (2003) 179-185
15. Counts R.B., Haisch C., Simon T., et al. Hemostasis in massively transfused trauma patients. Ann Surg 190 (1979) 91-99
16. Cosgriff N., Sauaia A., Kenny-Moynihan M., et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermoa and acidosis revisited. Journal of Trauma-Injury Infection and Critical Care 42 (1997) 857-861
17. Hunt B.J., Parrat R.N., Segal H., et al. Activation of coagulation. Ann Thorac Surg 65 (1998) 712-718
18. Jaggers J.J., Neal M.C., Smith P.K., et al. Infant cardiopulmonary bypass: a procoagulant state. Ann Thorac Surg 68 (1999) 513-520
19. Lewis J.H., Bontempo F.A., Awad S.A., et al. Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology 9 (1989) 710-714
20. Dzik W.H., Arkin C.F., Jenkins R.L., et al. Fibrinolysis during liver transplantation in humans: role of tissue plasminogen activator. Blood 71 (1998) 1090-1095
21. Porte R.J., Bontempo F.A., Knot F.A., et al. Systemic effects of tissue plasminogen activator associated with fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 47 (1989) 978-984
22. Gala B., Quintela J., Aguirrezabalaga J., et al. Benefits of recombinant activated factor VII in complicated liver transplantation. Transplantation Proc 37 (2005) 3919-3921
23. Herman H., Karina M., de Wolf J., et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation 71 (2001) 402-405
24. Linsman T., Leebeek F., Meijer K., et al. Recombinant factor VIIa improves clot formation but not fibrinolytic potential in patients with cirrhosis and during liver transplantation. Hepatology 35 (2002) 616-621
25. Guay J., Haig M., Lortie L., et al. Predicting blood loss in surgery for idiopathic scoliosis. Can J Anaesth 41 (1994) 775-781
26. Clark M.T., Green J.S., Harper W.M., et al. Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis. J Bone Joint Surg Br 79 (1997) 787-791
27. Culver D., Crawford J.S., Gardiner J.H., et al. Venous thrombosis after fractures of the upper end of the femur. A study of incidence and site. J Bone Joint Surg Br 52 (1970) 61-69
28. Kelsey J.L., Wood P.H., and Charnley J. Prediction of thromboemolism following total hip replacement. Clin Orthop Relat Res 114 (1976) 247-258
29. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 338S-400S
30. Blood Transfusion Task Force. Transfusion guidelines for massive blood loss. Clin Lab Haematol 8 (1988) 265-273
31. Levy J.H. Hemostatic agents. Transfusion 44 (2004) 58S-62S
32. Sedrakyan A., Treasure T., and Elefteriades J.A. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 128 (2004) 442-448
33. Katsaros D., Petricevic M., Wooodhall D.D., et al. Tranexamic acid reduces post-bypass blood loss. Ann Thorac Surg 61 (1996) 1131-1135
34. Menichetti A., Tritapep L., Ruvolo G., et al. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs EACA. J Cardiovasc Surg 37 (1996) 401-407
35. Weinstein M., and Ware A.J. Changes in von Willebrand factor during cardiac surgery effect of desmopressin acetate. Blood 71 (1988) 648-655
36. Hendriks H.G., Meijer K., de Wolf J.T., et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation. Transplantation 7 (2001) 402-405
37. Levy J.H. Massive transfusion coagulopathy. Semin Hematol 43 (2006) S59-S63
38. McCrath D.J., Cerboni E., Frumento R.J., et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100 (2005) 1576-1583